These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

451 related articles for article (PubMed ID: 9652221)

  • 1. Onchocerciasis control in Uganda.
    Ndyomugyenyi R
    World Health Forum; 1998; 19(2):192-5. PubMed ID: 9652221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Control of onchocerciasis.
    Boatin BA; Richards FO
    Adv Parasitol; 2006; 61():349-94. PubMed ID: 16735169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transmission of Onchocerca volvulus and prospects for the elimination of its vector, the blackfly Simulium neavei in the Mpamba-Nkusi focus in Western Uganda.
    Lakwo TL; Ndyomugyenyi R; Onapa AW; Twebaze C
    Med Vet Entomol; 2006 Mar; 20(1):93-101. PubMed ID: 16608493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of ivermectin treatment alone and when in parallel with Simulium neavei elimination on onchocerciasis in Uganda.
    Ndyomugyenyi R; Tukesiga E; Büttner DW; Garms R
    Trop Med Int Health; 2004 Aug; 9(8):882-6. PubMed ID: 15303993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progress towards the elimination of onchocerciasis as a public-health problem in Uganda: opportunities, challenges and the way forward.
    Ndyomugyenyi R; Lakwo T; Habomugisha P; Male B
    Ann Trop Med Parasitol; 2007 Jun; 101(4):323-33. PubMed ID: 17524247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Onchocerciasis and other eye problems in developing countries: a challenge for optometrists.
    Berger IB; Nnadozie J
    J Am Optom Assoc; 1993 Oct; 64(10):699-702. PubMed ID: 8245390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The elimination of the vector Simulium neavei from the Itwara onchocerciasis focus in Uganda by ground larviciding.
    Garms R; Lakwo TL; Ndyomugyenyi R; Kipp W; Rubaale T; Tukesiga E; Katamanywa J; Post RJ; Amazigo UV
    Acta Trop; 2009 Sep; 111(3):203-10. PubMed ID: 19446785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of ivermectin on illness and disability associated with onchocerciasis.
    Tielsch JM; Beeche A
    Trop Med Int Health; 2004 Apr; 9(4):A45-56. PubMed ID: 15078278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Onchocerciasis control by insecticides and chemotherapy stimulates agricultural development in Central West Africa.
    James ER
    J Agromedicine; 2004; 9(2):7-20. PubMed ID: 19785202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. River blindness. Protection for 54 cents a year.
    Vieta F
    UN Chron; 1998; (1):12-3. PubMed ID: 12348635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ivermectin and onchocerciasis: is it all solved?
    Hopkins AD
    Eye (Lond); 2005 Oct; 19(10):1057-66. PubMed ID: 16304585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adverse reactions to ivermectin treatment in Simulium neavei-transmitted onchocerciasis.
    Kipp W; Bamhuhiiga J; Rubaale T; Büttner DW
    Am J Trop Med Hyg; 2003 Dec; 69(6):621-3. PubMed ID: 14740878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mectizan as a stimulus for development of novel partnerships: the international organization's perspective.
    Etya'alé DE
    Ann Trop Med Parasitol; 1998 Apr; 92 Suppl 1():S73-7. PubMed ID: 9861271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Towards the elimination of onchocerciasis.
    Thylefors B; Alleman M
    Ann Trop Med Parasitol; 2006 Dec; 100(8):733-46. PubMed ID: 17227651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. After a decade of annual dose mass ivermectin treatment in Cameroon and Uganda, onchocerciasis transmission continues.
    Katabarwa M; Eyamba A; Habomugisha P; Lakwo T; Ekobo S; Kamgno J; Kuete T; Ndyomugyenyi R; Onapa A; Salifou M; Ntep M; Richards FO
    Trop Med Int Health; 2008 Sep; 13(9):1196-203. PubMed ID: 18631308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The challenge of establishing community-directed treatment with Mectizan in Uganda.
    Okwero P
    Ann Trop Med Parasitol; 1998 Apr; 92 Suppl 1():S171-4. PubMed ID: 9861290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interruption of the transmission of Onchocerca volvulus in the Kashoya-Kitomi focus, western Uganda by long-term ivermectin treatment and elimination of the vector Simulium neavei by larviciding.
    Lakwo T; Garms R; Wamani J; Tukahebwa EM; Byamukama E; Onapa AW; Tukesiga E; Katamanywa J; Begumisa S; Habomugisha P; Oguttu D; Byamukama E; Richards F; Unnasch TR; Katabarwa M
    Acta Trop; 2017 Mar; 167():128-136. PubMed ID: 28034767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Onchocerciasis Elimination Program for the Americas (OEPA).
    Sauerbrey M
    Ann Trop Med Parasitol; 2008 Sep; 102 Suppl 1():25-9. PubMed ID: 18718151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Control of onchocerciasis vectors in West Africa: description of the logistics adapted for a large-scale public health program].
    Hougard JM; Poudiougo P; Zerbo G; Meyer R; Guillet P; Agoua H; Seketeli A; Akpoboua A; Sowah S; Samba EM
    Sante; 1994; 4(6):389-98. PubMed ID: 7850190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of women in community-directed treatment with ivermectin for the control of onchocerciasis in Rukungiri district, Uganda: a knowledge, attitude and practice study.
    Katabarwa MN; Habomugisha P; Ndyomugyenyi R; Agunyo S
    Ann Trop Med Parasitol; 2001 Jul; 95(5):485-94. PubMed ID: 11487370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.